These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8285638)

  • 21. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice.
    Neyts J; De Clercq E
    J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models.
    Quenelle DC; Collins DJ; Pettway LR; Hartline CB; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antiviral Res; 2008 Aug; 79(2):133-5. PubMed ID: 18336926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative activity of various compounds against clinical strains of herpes simplex virus.
    Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
    Neyts J; Snoeck R; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.
    Lin JC; De Clercq E; Pagano JS
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model.
    de la Fuente R; Awan AR; Field HJ
    Antiviral Res; 1992 May; 18(1):77-89. PubMed ID: 1329646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
    Bischofberger N; Hitchcock MJ; Chen MS; Barkhimer DB; Cundy KC; Kent KM; Lacy SA; Lee WA; Li ZH; Mendel DB
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA).
    Bílá V; Otová B; Jelínek R; Sladká M; Mejsnarová B; Holý A; Kren V
    Folia Biol (Praha); 1993; 39(3):150-61. PubMed ID: 8157136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents.
    De Clercq E
    Drugs Exp Clin Res; 1990; 16(7):319-26. PubMed ID: 1965499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    Intervirology; 1997; 40(5-6):295-303. PubMed ID: 9675635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.
    Neyts J; Sobis H; Snoeck R; Vandeputte M; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):269-79. PubMed ID: 8390357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of various compounds against murine and primate polyomaviruses.
    Andrei G; Snoeck R; Vandeputte M; De Clercq E
    Antimicrob Agents Chemother; 1997 Mar; 41(3):587-93. PubMed ID: 9055998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
    Stals FS; Zeytinoglu A; Havenith M; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1993 Feb; 37(2):218-23. PubMed ID: 8383939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of acyclic nucleoside phosphonates as broad-spectrum antiviral agents.
    Naesens L; Balzarini J; De Clercq E
    Postepy Biochem; 1995; 41(5 Suppl):347-51. PubMed ID: 8797236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.